Efficiency of glydiab in therapy of patients with type 2 diabetes mellitus
https://doi.org/10.14341/probl11584
Abstract
Russian drug glydiab (Akrikhin, Russia) regulates basal and postprandial glycemia, glycated hemoglobin, and C peptide, normalizes lipid metabolism, arterial pressure, body weight, and lipid peroxidation in 82% patients with type 2 diabetes mellitus. An important clinical and pathogenetic characteristic of glydiab is prevention of excessive insulin production. Presumably, activation of antioxidant defense leads to improvement of insulin receptor interactions and insulin sensitivity. Glydiab is easy to use, well tolerated, easily available, and is recommended for the treatment of patients with type 2 diabetes mellitus.
About the Authors
V. A. GalenokNovosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City
Russian Federation
I. A. Krivosheeva
Novosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City
Russian Federation
O. V. Sazonova
Novosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City
Russian Federation
E. A. Yedemskaya
Novosibirsk State Medical Academy; Municipal Clinical Hospital No.1 of the Novosibirsk City
Russian Federation
References
1. Балаболкин М. И. Диабетология. - М., 2000.
2. Дедов И. И., Фадеев В. В. Введение в диабетологию: Руководство для врачей. - М., 1998.
3. Никифоров О. А. Перекисное окисление липидов и система антиоксидантной защиты у больных сахарным диабетом 1 типа: Дис. ... канд. мед. наук. - Новосибирск, 1999.
4. Планирование и проведение клинических исследований лекарственных средств / Под ред. Ю. Б. Белоусова. - М., 2000.
5. Таранов А. Г. Диагностические тест-системы. Радиоиммунный и иммуноферментный методы диагностики. - Новосибирск, 2000.
6. Фадеева Н. И., Балаболкин М. И., Мамаева Г. Г. и др. // Сахарный диабет. - 2001. - № 1. - С. 21-23.
7. Turner R. С. Matthews D R., Clark A. et al. // Baillieres Clin. Endocrinol. Metab. - 1998. - Vol. 12, N 2. - P 327-342.
8. UK Prospective Diabetes Study (UKPDS) Group // Lancet. - 1998. - Vol. 352. - P. 837-853.
Review
For citations:
Galenok V.A., Krivosheeva I.A., Sazonova O.V., Yedemskaya E.A. Efficiency of glydiab in therapy of patients with type 2 diabetes mellitus. Problems of Endocrinology. 2002;48(4):54-56. (In Russ.) https://doi.org/10.14341/probl11584
Views:
3370
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
